Trials confirm safety of AstraZeneca/Sputnik vaccine combo Russia
Mixing jabs from vaccines developed in the UK and Russia showed ?acceptable profile,? according to preliminary data Using the Russia-dev
Stay updated with breaking news from Sputnik Lite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mixing jabs from vaccines developed in the UK and Russia showed ?acceptable profile,? according to preliminary data Using the Russia-dev
/PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II...
MOSCOW, Feb. 14, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite). According to the interim results...
Mixing jabs from vaccines developed in the UK and Russia showed ?acceptable profile,? according to preliminary data Using the Russia-dev
Mixing jabs from vaccines developed in the UK and Russia showed ?acceptable profile,? according to preliminary data Using the Russia-dev